Stumpf Janice L, Liao Allison C, Nguyen Stacy, Skyles Amy J, Alaniz Cesar
J Am Pharm Assoc (2003). 2018 Jan-Feb;58(1):51-55. doi: 10.1016/j.japh.2017.09.002. Epub 2017 Oct 24.
To evaluate college-age women's knowledge of appropriate doses and potential toxicities of acetaminophen, competency in interpreting Drug Facts label dosing information, and ability to recognize products containing acetaminophen.
In this cross-sectional prospective study, a 20-item written survey was provided to female college students at a University of Michigan fundraising event in March 2015.
A total of 203 female college students, 18-24 years of age, participated in the study. Pain was experienced on a daily or weekly basis by 22% of the subjects over the previous 6 months, and 83% reported taking acetaminophen. The maximum 3-gram daily dose of extra-strength acetaminophen was correctly identified by 64 participants; an additional 51 subjects indicated the generally accepted 4 grams daily as the maximum dose. When provided with the Tylenol Drug Facts label, 68.5% correctly identified the maximum amount of regular-strength acetaminophen recommended for a healthy adult. Hepatotoxicity was associated with high acetaminophen doses by 63.6% of participants, significantly more than those who selected distracter responses (P < 0.001). Knowledge of liver damage as a potential toxicity was correlated with age 20 years and older (P < 0.001) but was independent from race and ethnicity and level of alcohol consumption. Although more than one-half of the subjects (58.6%) recognized that Tylenol contained acetaminophen, fewer than one-fourth correctly identified other acetaminophen-containing products.
Despite ongoing educational campaigns, a large proportion of the college-age women who participated in our study did not know and could not interpret the maximum recommended daily dose from Drug Facts labeling, did not know that liver damage was a potential toxicity of acetaminophen, and could not recognize acetaminophen-containing products. These data suggest a continued role for pharmacists in educational efforts targeted to college-age women.
评估大学适龄女性对乙酰氨基酚适当剂量和潜在毒性的了解、解读药品说明书给药信息的能力以及识别含乙酰氨基酚产品的能力。
在这项横断面前瞻性研究中,于2015年3月在密歇根大学的一次筹款活动中,向女大学生提供了一份包含20个条目的书面调查问卷。
共有203名年龄在18至24岁之间的女大学生参与了该研究。在过去6个月中,22%的受试者每天或每周都会经历疼痛,83%的受试者报告服用过乙酰氨基酚。64名参与者正确识别出了强效乙酰氨基酚的每日最大剂量为3克;另有51名受试者指出普遍认可的每日最大剂量为4克。在查看泰诺药品说明书时,68.5%的人正确识别出了健康成年人推荐使用的常规强度乙酰氨基酚的最大量。63.6%的参与者认为高剂量乙酰氨基酚会导致肝毒性,这一比例显著高于选择干扰项的参与者(P < 0.001)。对肝损伤作为潜在毒性的认知与20岁及以上的年龄相关(P < 0.001),但与种族和民族以及饮酒量无关。虽然超过一半的受试者(58.6%)认识到泰诺含有乙酰氨基酚,但正确识别出其他含乙酰氨基酚产品的人不到四分之一。
尽管开展了持续的教育活动,但参与我们研究的很大一部分大学适龄女性并不了解也无法解读药品说明书上推荐的每日最大剂量,不知道肝损伤是乙酰氨基酚的潜在毒性,并且无法识别含乙酰氨基酚的产品。这些数据表明药剂师在针对大学适龄女性的教育工作中仍需发挥作用。